Chung Jason Zhi Yong, Dallas Jones Graham Ross
Department of Chemical Pathology, SydPath, St Vincent's Hospital, Sydney, Victoria St, Darlinghurst, NSW 2010, Australia.
Department of Chemical Pathology, SydPath, St Vincent's Hospital, Sydney, Victoria St, Darlinghurst, NSW 2010, Australia; Faculty of Medicine, University of New South Wales, Randwick, NSW 2031, Australia.
Clin Biochem. 2015 Aug;48(12):807-10. doi: 10.1016/j.clinbiochem.2015.05.004. Epub 2015 May 11.
Elevations of serum cardiac troponin T (cTnT) have been described in patients with end stage chronic kidney disease (CKD) although the mechanism is unknown, whether from increased production or decreased clearance. Less is known about cTnT in short term changes in renal function and in lesser degrees of renal impairment.
This study aimed to investigate the effect of renal function changes on cTnT within individuals and characterise the distribution of cTnT according to renal function in the population.
A hospital laboratory database extract was performed for paired creatinine and cTnT results. cTnT was compared with estimated glomerular filtration rate (eGFR) at the population level. In individuals who had undergone repeat testing, changes in cTnT were compared with corresponding changes in creatinine.
At the population level, 17,113 cTnT and creatinine measurements from 10,418 patients demonstrated rising cTnT with falling eGFR, with no eGFR threshold for this effect. Of these, 3108 pairs of results were obtained from patients who had undergone repeat testing. The median retesting interval was 15 h (interquartile range: 7-25 h). Within individuals, the magnitude of changes in cTnT approximated 33% of changes in creatinine.
At the population level, moderate reductions in GFR (30-59 mL/min/1.73 m(2)) corresponded to a median cTnT above the 14 ng/L upper reference limit. The modest association between changes in cTnT and creatinine within individuals in the short term further highlights the need for caution when interpreting troponin elevations in this setting.
终末期慢性肾脏病(CKD)患者中血清心肌肌钙蛋白T(cTnT)水平升高已有报道,但其机制尚不清楚,是由于生成增加还是清除减少。关于肾功能短期变化以及轻度肾功能损害时cTnT的情况知之甚少。
本研究旨在调查个体肾功能变化对cTnT的影响,并根据人群中的肾功能情况描述cTnT的分布特征。
从医院实验室数据库中提取肌酐和cTnT的配对结果。在人群水平上比较cTnT与估算肾小球滤过率(eGFR)。对接受重复检测的个体,将cTnT的变化与肌酐的相应变化进行比较。
在人群水平上,来自10418例患者的17113次cTnT和肌酐测量结果显示,随着eGFR下降,cTnT升高,且不存在该效应的eGFR阈值。其中,3108对结果来自接受重复检测的患者。再次检测的中位间隔时间为15小时(四分位间距:7 - 25小时)。在个体内部,cTnT变化幅度约为肌酐变化的33%。
在人群水平上,肾小球滤过率适度降低(30 - 59 mL/min/1.73 m²)对应cTnT中位数高于14 ng/L的参考上限。短期内个体cTnT变化与肌酐变化之间的适度关联进一步凸显了在此情况下解释肌钙蛋白升高时需谨慎的必要性。